References
- . Rosenbauer J, Icks A, Giani G. Incidence and prevalence of childhood type 1 diabetes mellitus in Germany—model-based national estimates. J Pediatr Endocrinol Metab. 2002;15(9):1497–1504
- . Gale EA. The rise of childhood type 1 diabetes in the 20th century. Diabetes. 2002;51(12):3353–3361
- . Onkamo P, Väänänen S, Karvonen M, Tuomilehto J. Worldwide increase in incidence of Type 1 diabetes—the analysis of the data on published incidence trends. Diabetologia. 1999;42(12):1395–1403
- . Grabert M, Schweiggert F, Holl RW. A framework for diabetes documentation and quality management in Germany: 10 years of experience with DPV. Computer Methods and Programs in Biomedicine. 2002;69(2):115–121
- . Jakisch BI, Wagner VM, Heidtmann B, ; German/Austrian DPV Initiative and Working Group for Paediatric Pump Therapy. Comparison of continuous subcutaneous insulin infusion (CSII) and multiple daily injections (MDI) in paediatric Type 1 diabetes: a multicentre matched-pair cohort analysis over 3 years. Diabet Med. 2008; 25(1):80–85
- . Paris CA, Imperatore G, Klingensmith G, . Predictors of insulin regimens and impact on outcomes in youth with type 1 diabetes: the SEARCH for Diabetes in Youth study. J Pediatr. 2009;155(2):183–189
- . Scheiner G, Sobel RJ, Smith DE, . Insulin pump therapy: guidelines for successful outcomes. Diabetes Educ. 2009;35( suppl 2):29S–41S
- . Pankowska E, Blazik M, Dziechiarz P, Szypowska A, Szajewska H. Continuous subcutaneous insulin infusion vs multiple daily injections in children with type 1 diabetes: a systemativc review and metaanalysis of randomized controlled trials. Pediatr Diabetes. 2000;10:52–58
- . Plank J, Siebenhofer A, Berghold A, . Systematic review and meta-analysis of short acting insulin analogues in patients with diabetes mellitus. Arch Intern Med. 2005;165(12):1337–1344
- . Weintrob N, Benzaquen H, Galatzer A, . Comparison of continuous subcutaneous insulin infusion and multiple daily injection regimens in children with type 1 diabetes: a randomized open crossover trial. Pediatrics. 2003;112(3 pt 1):559–564
- . Weissberg-Benchell J, Antisdel-Lomaglio J, Seshadri R. Insulin pump therapy: a meta-analysis. Diabetes Care. 2003;26(4):1079–1087
- . Kapellen TM, Heidtmann B, Bachmann J, Ziegler R, Grabert M, Holl RW. Indications for insulin pump therapy in different age groups: an analysis of 1,567 children and adolescents. Diabet Med. 2007;24(8):836–842
- . Eugster EA, Francis G; Lawson-Wilkins Drug and Therapeutics Committee. Position statement: Continuous subcutaneous insulin infusion in very young children with type 1 diabetes. Pediatrics. 2006; 118(4):e1244–e1249
- . Kaufman FR, Halvorson M, Carpenter S, Devoe D, Pitukcheewanont P. Insulin pump therapy in young children with diabetes. Diabetes Spectrum. 2001;14:84–89
- . Rodrigues IA, Reid HA, Ismail K, Amiel SA. Indications and efficacy of continuous subcutaneous insulin infusion (CSII) therapy in Type 1 diabetes mellitus: a clinical audit in a specialist service. Diabet Med. 2005;22(7):842–849
- . Fox LA, Buckloh LM, Smith SD, Wysocki T, Mauras N. A randomized controlled trial of insulin pump therapy in young children with type 1 diabetes. Diabetes Care. 2005;28(6):1277–1281
- . Mack-Fogg JE, Orlowski CC, Jospe N. Continuous subcutaneous insulin infusion in toddlers and children with type 1 diabetes mellitus is safe and effective. Pediatr Diabetes. 2005:61(1):17–21
- . Berghaeuser MA, Kapellen T, Heidtmann B, Haberland H, Klinkert C, Holl RW; German working group for insulin pump treatment in paediatric patients. Continuous subcutaneous insulin infusion in toddlers starting at diagnosis of type 1 diabetes mellitus. A multicenter analysis of 104 patients from 63 centres in Germany and Austria. Pediatr Diabetes. 2008; 9(6):590–595
- . Kapellen TM, Wolf J, Rosenbauer J, ; DPV-Science-Initiative. Changes in the use of analogue insulins in 37 206 children and adolescents with type 1 diabetes in 275 German and Austrian centres during the last twelve years. Exp Clin Endocrinol Diabetes. 2009; 117(7):329–335
- . Klinkert C, Bachran R Heidtmann B, Grabert M, Holl RW; DPV-Initiative. Age-specific characteristics of the basal insulin-rate for pediatric patients on CSII. Exp Clin Endocrinol Diabetes. 2008; 116(2):118–122
- . Danne T, Aman J, Schober E; ANA 1200 Study Group. A comparison of postprandial and preprandial administration of insulin aspart in children and adolescents with type 1 diabetes. Diabetes Care. 2003; 26(8):2359–2364
- . Danne T, Råstam J, Odendahl R, . Parental preference of prandial insulin aspart compared with preprandial human insulin in a basal-bolus scheme with NPH insulin in a 12-wk crossover study of preschool children with type 1 diabetes. Pediatr Diabetes. 2007;8(5):278–285
- . Rutledge KS, Chase P, Klingensmith GJ, Walravens PA, Slover RH, Garg SK. Effectiveness of postprandial Humalog in toddlers with diabetes. Pediatrics. 1997;100(6):968–972
- . Insulin Pumpers. http://www.insulin-pumpers.org/pkids.shtml. Accessed April 20, 2010
- . Wood JR, Moreland EC, Volkening LK, Svoren BM, Butler DA, Laffel LMB. Durability of insulin pump use in pediatric patients with type 1 diabetes. Diabetes Care. 2006;29(11):2355–2360
- . Hofer SE, Heidtmann B, Raile K, ; for the DPV-Science-Initiative and the German working group for insulin pump treatment in pediatric patients. Discontinuation of insulin pump treatment in children, adolescents, and young adults. A multicenter analysis based on the DPV database in Germany and Austria [published online ahead of print June 29, 2009]. Pediatr Diabetes.
- . Barbar GS, Ali O, Parton EA, Hoffmann RG, Alemzadeh R. Factors associated with adherence to continuous subcutaneous insulin infusion with pediatric diabetes. Diabetes Technol Ther. 2009;11(3):131–137